Related Experiment Video
Updated: May 11, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
A patient with severely reduced LV function and electrical storm saved by wearable cardioverter-defibrillator: a case
Margit Strauss1, Kleopatra Kouraki, Alexandros Skarlos
1Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063, Ludwigshafen, Germany. straussm@klilu.de
Insights
The wearable cardioverter-defibrillator (WCD) effectively managed electrical storm in a patient with reduced heart function. This case highlights the WCD
Area of Science:
- Cardiology
- Medical Technology
Background:
- Wearable cardioverter-defibrillators (WCDs) manage sudden cardiac death (SCD) risk when implantable defibrillators are not yet indicated.
- Patients with severely reduced left ventricular function and ventricular tachycardia (VT) are at high risk for SCD.
Observation:
- A 41-year-old patient with newly diagnosed reduced left ventricular function and VT received a WCD.
- The patient experienced an electrical storm 4 weeks post-discharge, with the WCD delivering appropriate shocks.
- A magnetic field imaging (MFI) for risk stratification yielded normal results.
Findings:
- The WCD demonstrated efficacy in managing a life-threatening electrical storm.
- Amiodarone administration stabilized the patient's cardiac rhythm during hospitalization.
- Despite normal MFI results, an implantable cardioverter-defibrillator (ICD) was implanted, showing no further arrhythmias in 1-year follow-up.
Implications:
- WCDs represent a valuable tool for managing temporary high risk of SCD.
- This case suggests novel approaches to SCD risk stratification may be needed.
- Early intervention with WCDs can be life-saving in select cardiac patients.
Abstract:
The wearable cardioverter-defibrillator (WCD) is indicated in patients who are considered to be at temporarily high risk for sudden cardiac death (SCD), when an implantable defibrillator is not yet clearly indicated. We report the case of a 41-year-old patient with a newly diagnosed severely reduced left ventricular (LV) function for suspected myocarditis and repeated nonsustained ventricular tachycardia (VT). This patient was supplied with a WCD who came back to the hospital 4 weeks after discharge with an electrical storm and adequate discharge of the WCD. After application of amiodarone, no further arrhythmias were detected during intrahospital course. For further risk stratification, we performed a magnetic field imaging (MFI), that was reported to be useful in risk assessment of SCD in patients with ischemic cardiomyopathy. This measurement showed a normal result, but we decided to give an implantable cardioverter-defibrillator (ICD) to the patient. During a follow-up of 1 year, no further arrhythmias occurred. With this case, we report the efficacy of a WCD, which is a novel tool in patients at temporarily high risk of SCD and we report a novel method of risk stratification in patients with a high risk of SCD.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

